BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 18790079)

  • 1. Erythrocyte-based Pig-a gene mutation assay: demonstration of cross-species potential.
    Phonethepswath S; Bryce SM; Bemis JC; Dertinger SD
    Mutat Res; 2008 Dec; 657(2):122-6. PubMed ID: 18790079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pig-a mutation: kinetics in rat erythrocytes following exposure to five prototypical mutagens.
    Phonethepswath S; Franklin D; Torous DK; Bryce SM; Bemis JC; Raja S; Avlasevich S; Weller P; Hyrien O; Palis J; Macgregor JT; Dertinger SD
    Toxicol Sci; 2010 Mar; 114(1):59-70. PubMed ID: 19965957
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo mutation assay based on the endogenous Pig-a locus.
    Bryce SM; Bemis JC; Dertinger SD
    Environ Mol Mutagen; 2008 May; 49(4):256-64. PubMed ID: 18288722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. When pigs fly: immunomagnetic separation facilitates rapid determination of Pig-a mutant frequency by flow cytometric analysis.
    Dertinger SD; Bryce SM; Phonethepswath S; Avlasevich SL
    Mutat Res; 2011 Apr; 721(2):163-70. PubMed ID: 21277384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Manifestation of Pig-a mutant bone marrow erythroids and peripheral blood erythrocytes in mice treated with N-ethyl-N-nitrosourea: direct sequencing of Pig-a cDNA from bone marrow cells negative for GPI-anchored protein expression.
    Kimoto T; Suzuki K; Kobayashi XM; Dobrovolsky VN; Heflich RH; Miura D; Kasahara Y
    Mutat Res; 2011 Jul; 723(1):36-42. PubMed ID: 21549855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an in vivo gene mutation assay using the endogenous Pig-A gene: I. Flow cytometric detection of CD59-negative peripheral red blood cells and CD48-negative spleen T-cells from the rat.
    Miura D; Dobrovolsky VN; Kasahara Y; Katsuura Y; Heflich RH
    Environ Mol Mutagen; 2008 Oct; 49(8):614-21. PubMed ID: 18626999
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of mutation in the rat Pig-a assay: I) studies with bone marrow erythroid cells.
    Revollo JR; Pearce MG; Dad A; Petibone DM; Robison TW; Roberts D; Dobrovolsky VN
    Environ Mol Mutagen; 2018 Oct; 59(8):722-732. PubMed ID: 30091272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applying the erythrocyte Pig-a assay concept to rat epididymal sperm for germ cell mutagenicity evaluation.
    Ji Z; LeBaron MJ
    Environ Mol Mutagen; 2017 Aug; 58(7):485-493. PubMed ID: 28714084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD48-deficient T-lymphocytes from DMBA-treated rats have de novo mutations in the endogenous Pig-a gene.
    Dobrovolsky VN; Revollo J; Pearce MG; Pacheco-Martinez MM; Lin H
    Environ Mol Mutagen; 2015 Oct; 56(8):674-83. PubMed ID: 26033714
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interlaboratory trial of the rat Pig-a mutation assay using an erythroid marker HIS49 antibody.
    Kimoto T; Horibata K; Chikura S; Hashimoto K; Itoh S; Sanada H; Muto S; Uno Y; Yamada M; Honma M
    Mutat Res; 2013 Aug; 755(2):126-34. PubMed ID: 23792374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of mutation in the rat Pig-a assay: II. Studies with bone marrow granulocytes.
    Dad A; Revollo JR; Petibone DM; Pearce MG; Heflich RH; Dobrovolsky VN
    Environ Mol Mutagen; 2018 Oct; 59(8):733-741. PubMed ID: 30091248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylphosphatidylinositol (GPI) anchored protein deficiency serves as a reliable reporter of Pig-a gene Mutation: Support from an in vitro assay based on L5178Y/Tk
    Bemis JC; Avlasevich SL; Labash C; McKinzie P; Revollo J; Dobrovolsky VN; Dertinger SD
    Environ Mol Mutagen; 2018 Jan; 59(1):18-29. PubMed ID: 29115020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse Pig-a and micronucleus assays respond to N-ethyl-N-nitrosourea, benzo[a]pyrene, and ethyl carbamate, but not pyrene or methyl carbamate.
    Labash C; Avlasevich SL; Carlson K; Berg A; Torous DK; Bryce SM; Bemis JC; MacGregor JT; Dertinger SD
    Environ Mol Mutagen; 2016 Jan; 57(1):28-40. PubMed ID: 26186091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Manifestation and persistence of Pig-a mutant red blood cells in C57BL/6 mice following single and split doses of N-ethyl-N-nitrosourea.
    Bhalli JA; Pearce MG; Dobrovolsky VN; Heflich RH
    Environ Mol Mutagen; 2011 Dec; 52(9):766-773. PubMed ID: 22167887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Erythrocyte-Based Pig-a Gene Mutation Assay.
    Bemis JC; Hall NE; Dertinger SD
    Methods Mol Biol; 2019; 2031():29-57. PubMed ID: 31473953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pig-a mutations in bone marrow erythroblasts of rats treated with 7,12-dimethyl-benz[a]anthracene.
    Revollo JR; Dad A; Pearce MG; Mittelstaedt RA; Robison TW; Dobrovolsky VN
    Mutat Res Genet Toxicol Environ Mutagen; 2019 Dec; 848():503106. PubMed ID: 31708078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Accumulation and persistence of Pig-A mutant peripheral red blood cells following treatment of rats with single and split doses of N-ethyl-N-nitrosourea.
    Miura D; Dobrovolsky VN; Kimoto T; Kasahara Y; Heflich RH
    Mutat Res; 2009; 677(1-2):86-92. PubMed ID: 19501187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The in vivo Pig-a gene mutation assay, a potential tool for regulatory safety assessment.
    Dobrovolsky VN; Miura D; Heflich RH; Dertinger SD
    Environ Mol Mutagen; 2010; 51(8-9):825-35. PubMed ID: 20857433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring genotoxicity in patients receiving chemotherapy for cancer: application of the PIG-A assay.
    Horibata K; Ukai A; Ishikawa S; Sugano A; Honma M
    Mutat Res Genet Toxicol Environ Mutagen; 2016 Sep; 808():20-6. PubMed ID: 27637482
    [TBL] [Abstract][Full Text] [Related]  

  • 20. International Pig-a gene mutation assay trial: evaluation of transferability across 14 laboratories.
    Dertinger SD; Phonethepswath S; Weller P; Nicolette J; Murray J; Sonders P; Vohr HW; Shi J; Krsmanovic L; Gleason C; Custer L; Henwood A; Sweder K; Stankowski LF; Roberts DJ; Giddings A; Kenny J; Lynch AM; Defrain C; Nesslany F; van der Leede BJ; Van Doninck T; Schuermans A; Tanaka K; Hiwata Y; Tajima O; Wilde E; Elhajouji A; Gunther WC; Thiffeault CJ; Shutsky TJ; Fiedler RD; Kimoto T; Bhalli JA; Heflich RH; MacGregor JT
    Environ Mol Mutagen; 2011 Dec; 52(9):690-8. PubMed ID: 21910140
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.